Philip Morris
Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
Fields
- Author
- Ecobichon, D.J.
- Wexler, L.M.
- Wu, J.M.
- Wexler, L.M.
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Named Person
- Wexler, L.M.
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Author (Organization)
- Intl Symposium Environment Tobacco Smoke
- Mcgill Univ
- Ny Medical College
- Mcgill Univ
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- nic02a00
Document Images
i
l Tobacco
; Envlronmerital I
F Smoke
Proceedings of th:: lnternw2onal
Symposium at 'UwvQrsi~y
1989
Donald J. Eeohi6y,?n
McGill Universiry
Joseph A Wu
New York Medi~~ fbllege
1N.ZX kQr , , L. M ,
C~,..pt.
aJ Cu. L. s. l~ ~ it. ce :
L LErc Lvr¢ c J Zo~. w+.d~~ .. ~ ~o.
~ ~...4 ZQSO~ ~ K, 13Ci
Editors and Osganfzers of the Sym,irosium.
~r3-~ds
~T
Leacington Books
D.C. Heath and Company/Lexington, MassachusettslToronto

Library o%Congrtss Cataloging-in-Publication Data
Environmental tobacco smoke : proceedings oPthe international
symposium at McGill UniversiryJ Donald). Ecobichon, Joseph M. Wu,,
editors.
p. cm.
ISBN 0-669-24365-3 (alk: paper)
1. Passive smoking-Health aspeas-Congresses. 2. Tobacco smoke
pollution-Hcalth aspects-Congresses. 3. Tobacco smoke-
Congresses. 1. Ecobichon, Donald J. II. Wu,,Joseph M.
lll. International Symposium on Environmental Tobacco Smoke (1989 :
McGill Universiry).
RA1242.T6E58 1990
616.86'5'071-d'c20 89-49011
CIP
Copyright m 1990 by Lexington 9ooks
All rights reserved. No part of this publication
may be reproduced or transmitted in any form or
by any means, electronic or mechanicalincluding
photocopy, recording, or any, information storage
or retrieval system, without permission in writing
from the publisher.
Published'simultaneously in Canada
Printed in the United'States of America
International Standard Book Number: 0-669-24365-5
Library of Congress Catalog Card'Number:
The paper used in this publication meets
the minimum requirements of~Amerian NationallStandard
for Information Scienees-Permanence of Paper
for Printed Library Materials, ANSI Z39.48-1984.
O,.
8990919287654321

8
Environmental Tobacco Smoke and
Cardiovascular Disease: A Critique of
the Epidemiological Literature and
Recommendations for Future Research
3
ri
LawrenceM. Wexier, Ph.D.
New York Medical College
T his paper evaluates the current epidemiological literature examining
the possible relationship between exposure to environmental tobacco:
smoke ("ETS") and cardiovascular disease. Based on the available
evidence, it is this author's opinion that it has nor been demonstrated that
exposure to ETS increases the risk of cardiovascular disease. This paper eval-
uates seven studies that examine this issue (table 8-1). Five of the studies are
prospective in nature, one is a case-control design (retrospective); and one is
am experimental design examining the biological plausibility of a link be-
tween ETS and cardiovascular disease.
Several key points of epidemiology need to be mentioned here, and'
shoul& be kept in mind when reading,the critiques of the seven studies. To
prove causality five criteria need to be met. The first relates to the strength
of the association. There are three elements to this criterion. First, there must
be a statistically significant increase in the incidence of the disease in the
exposed population compared with the non-exposed population. Second, for
the association to be regarded as meaningful, a relative risk of 2.0 or greater
is generally considered necessary. Third~ the association should also be dose
dependent, i.e., higher doses are associated with higher incidence of: disease.
The second point is that consistency of the association must exist among
the relevant studies. This means that similar rates of' disease musr occur at
different times and places, under~ comparable study designs.
A third point deals with the temporali aspect of the association. This
means that exposure to ETS should have occurred at a reasonable time before
the onset off disease, given what is known about how long it takes for cardio-
vascular disease to develop.
A fourth point is specificity of the assodation. With ETS, this means that
exposure to ETS must be shown to be associated with cardiovascular disease
while controlling for all confounding variables.

140 - Environmental'Tobacco Smoke
Tablt 8-1
Env'uonmentaliTobacco Smoke and Cardiovascular Disease
Design
1. Hirayama Sixteen year prospective
(1981,,1984)' study of nonsmoking
Japanese women
classified at start of
follow-up by the smoking
status of eheir husbands.
142;857 women 40 and
over (91,540 nonsmoking
wives),
2. Garland Prospective-enrolled
(1i985) 82% of'adults ages 50-
79 between 1972-1974
in a community in San
Diego. Blood pressure
and plasma cholesterol
measured at entry;
interviewed a111cohort of
695 current married non-
smoking women free of
heart disease; ten year
follow-up.
3. Gillis (1989) Two urban communities
in Scotland. Ten year
follow-up report. 8,128
adults ages 45-64.
Findings
l.,Relative risk of 1.31
for ischemic heart
disease for
nonsmoking,women
whose husbands
smoked'> 19
cigarettes per day
compared with
nonsmoking women
whose husbands did
not smoke.
2. Mantel-Haensze)
signifiaant at
p < .019, 1984.
3. °Passive smoking
did not seem to
increase the risk of
developing...
ischemic heart
disease °
-Hirayama, 1981.
1. Elevated cardiac
disease deaths in
non-smoking
women, ages 50-79,
whose husbands
were former or
current smokers.
2. 19 deaths from
ischemic heart
disease after ten
years.
Non-smokers exposed
totigzrette smoke in,
their homes had a
slightly higher rate of
myocardial infarction
than those unexposed.
Met6'odological
Problems
11. Potential biases.
2. Misciassificanon of
smokers and non-
smokers.
3. Misclassification of
dose response
(number of'cigarettes
smoked'per day):,
4'. Looked arspouse
exposure onl), not
workplace.
5, No control for
indoor air pollution,
e.g., cooking witfl,
kerosene stoves.
6. Not representative of
Japanese
population-only
agriculture
represented.
7. Non-random samp)e
of prefectures-only,
a convenience
sample.
1. Some misgrouping-
wives of former
smoker were
grouped with wives
of current smokers.
2. Small sample sizes,
valbe may be
inappropriate based
on Mantel-Haenszel,
and may only be an
approximation; still
pwasonlyp<.10.
3. 15 of 19 deaths
occurred in
nonsmoking women
married to former
smokers-puzzling
results.
1. SmallIsample size.
1'. Few of the results
were statistically
significant.
Table l
4. Svenc
(198'
5. Hcls
(19b

Table 8-1 continued
~logical
kms
liases. 4. Svendsen
~cation of (1987)
d non,
cation of
se
cigarettes
r d'ay);.
spouse
nly, not
~ for
pollhtion,.
~g with
oves.
Kntarivr of
-only
m sample
res-onh_
ce
~ouping--
~rmer
re
th wives,
mokers.
Ie sizes,
be
te based
I'l'aenszelJ,
lii be an
ion; still
p < .10.
aths
5'. Helsing.
(1988)
.
g women
former
puzzling
~le size.,
t results
ically
Design
1. Multiple Risk Factor
Intervention Trial
(MRFIT):
2. Randomized primary
prevention trial
designed to test the
effect of a multifactor,
intervention program
on mortality fromm
coronary heart disease
in men with previous
cardiac episodes.
3: Memwere chosen for
participation ifithey,
had at least two of
three risk factors for
heart disease
(smoking, high
cholesterol levels, , high
blood pressure).
1. Twelve year study,
executed in
Washington County,
Maryland:
2. July, 1963 census of
91,909 people.
3. Whites only.
4. Death certificates
collected from July,
1963 through July,
1975:
S. Non-smokers, ages 25
and'over.
6. 4,162 men and 14,873
women.
ETS and Cardiovascular Disease 141
Findings
1. No difference
between smoking
wives and
nonsmoking wives
for non-smoking
men for blood
pressure or
cholesterol.
2. Roughly two-fold
increase in risk of
CHD mortality and
morbidity among,
nonsmoking men
exposed to ETS of
wives.
1. Death rates from
arteriosclerotic heart
disease were higher
among men
(Relative risk =
1.31),and women
(relative risk =
1.24) who lived
with,smokers in
119631 after
adjustmentfor age,
marital statusyears
of'schooling, and
quality of!housing
index.
2. For women; relative
risk increased
significantly.
(p < .OOS) for dose
response (increasing
levels of exposure)..
3. Men-4itde evidence
of a dose response
relationship.
MetHodolog,cal
Problems
1.,Sample size small.
2. Results-not
statistically
significant.
1. Only smoking data
collected on every
person was in 1963.
2. No measurement of',
changes in smoking
habits.
3. No data on
household changes
from 1963-1975.
4. Very little other risk
factor data for heart
disease.
S.,No diet, exercise,
blood pressure,,
cholesterol data, or
ETS exposure outof
home.

Methodological
Design Findings Problims
6. Lee (1986)i Case-conerol; ischemic heart disease Case-control
cases and controls did methodological issues.
not show a statistically
significant difference in
their exposure to
involuntary smoking,
based on smoking
habits of spouses or on
an index accounting
for exposure at home,
at work, and during
travel and leisure.
7. Aronow Experimental design. ETS aggravates angina 1. Endpoinnof angina
(1978) pectoris. based on subjcaivc
evaluation.
2. Stress not controlled
fon
se(
etr
tic
hu
W
rel
th,
0..
he
sn
hi
ri`
th
Ti
pj
tl-.
The fifth point is that there must be biological plausibility. This means
that under experimental conditions exposure to the pertinent substance (or
similar substances) must be shown to cause biological changes that can lead
to the disease in question.
All' five conditions must be met for causality to be established. We will
return to these points at the end of the paper, when we examine recommen-
dations for future research,
I. Summary of Epidemiological Literature
A. Prospective Studies
1. Huayama. Hirayama (1984) conducted a prospective cohort study in 29
health center districts in six prefectures in Japan between January 1966 and
December 1981. In total, 265,118 adults (122,261 men and 142,857 women)
aged 40 years and over were followed. Ninety-five percent of the census pop-
ulation was interviewed between October and' December 1965. Also,
Hirayama established a record' linkage system under which he gathered and
analyzed death, certificates, risk factor records, and a residence list obtained
by an annual census. Questions on smoking habits were asked independently
of husbands and wives at the beginning of the study. There were 91,540 non
smoking married women whose husbands' smoking habits were reported by
qµestionnaire.
ex
(a
n,
ir.
p
st
K
ft
sl
c~..
h
E
Ii

ETS and Cardiovascular Disease 143
PologicaL
bbJems
ol
gical'issues.
~t of angina
k~ subjpctive
`on.
bt controlled
peans.
Pe (or
` lead
t wil1
men-
L~n 29
and
irnen)
Pop-
so,
and
~ ined
ently
non-
d by
In 1981, Hirayama (1981) concluded that "husbands' smoking habitss
seemed to have no effect on their non-smoking wives' risk of'developing isch-
emic heart disease." Hirayama reported' age/occupation standardized risk ra-
tios for ischemic heart disease in non-smoking women by smoking habit of
husband. When the husband was a non-smoker, the relative risk was 1.0.
When the husban&was an ex-smoker or srnoke& 1-19 dgarettes per day, the
relative risk was .97. When the husband smoked 20:or more cigarettes/day
the relative risk was 1.03, and the reported p value was not significant at
0:393.
Hirayama (19g4)~ in a 1984 paper, reported an elevated risk of'ischemic
heart disease morbidity based on, further analyses. The relative risk for non-
smoking married women for husbands who were non-smokers was 1.0; for
husbands who were ex-smokers or smoked 1-19 cigarettes/day the relative
risk was 1.10;,and for husbands who smoke&20 or, more cigarettes per day,
the relative risk was 1.31, with a 90% confidence interval of 1.06 to 1.63.
The reported p value was significant at .019.
Hirayama's study has severali major methodological problems. The firstt
problem is potential misclassification of smokers and non-smokers. Many of
the wives who stated they were non-smokers may in, fact be ex-smokers or
even current smokers, and thus likely to have had or continue to have direct
(as opposed to indirect), exposure to cigarette smoke.
The second problem is that Hirayama's study included a disproportionate
number of women of lower socioeconomic status. In Japan, these women live
in much closer proximity to: their cooking quarters and may have more ex-
posure to charcoal or kerosene stoves than women of' higher socioeconomic
status. This exposure has been associated with lung cancer in women iniHong
Kong.. Women in Japan, of a higher socioeconomic status live farther away
from their kitchens and are more likely to use electric burners. The Hirayama
study failed to controlI for these confounding variables, which may be asso-
ciated with ischemic heart disease.
A third problem is the misclassification of dose response. Ex-smoking
husbands were lumped with currenti cigarette smokers of 1-19 cigarettes/day:
Because ex-smokers are very different in their cigarette exposure rates and
lifestyles than smokers of 1-19 cigarettes/day, this could skew the data.
A fourth problem is that Hirayama only examined the exposure of the
wife in the context of the husband's cigarette smoking behavior. No attempt
was made to quantify any exposure to ETS outside of the home, such as in
the workplace.
A fifth problem is that the Hirayama study was not representative of
Japanese society but only of an~agriculturally based population, which is not
typical for Japan. In addition, six prefectures were chosen to participate in
the study based on the fact that they appear to have had the best conditions
for collecting data. Hence, random sampling was not used'.

A sixth problem is that the Hirayama study did not control for other risk
factors associate& with cardiovascular disease, i.e., systolic blood pressure
and plasma cholesterol.
Although the Hirayama study offers a large prospective cohort to ex-
amine the relationship between presumed exposure to environmental tobacco
smoke and ischemic heart disease, one can not draw definitive conclusions
because of the aforementioned methodological problems.
2. Garland. Garlan&(1985)' conducted a prospective cohort study commen-
cing in 1972-1974 in Rancho Bernardo, a white middle-class suburb of San
Diego, California. The entire adult population was invited to participate, of
which 82% agreed. The authors report that the respondents were represen-
tative of the total population with regard'to age and'sex.
All respondents were administered a standardized' inventory, including
questions about age, cigarette smoking, history of past hospitalizations for
heart attack, heart failure or stroke, and number, of' years marriedi Cigarette
smoking was assessed as current, former or never. Only current smokers were
asked the number of cigarettes they smoked' per day. No data were obtained
for duration of'smoking. In addition, blood pressure and plasma cholesterol
were obtained.
An annual mailing was utilized to determine vital status for the next ten
years. Death certificates were obtained for all' decedents. Diagnosis of isch-
emic heart disease was validated by interviews with family and physicians,
andlor examination of' hospital records, for 85% of the deceased group:
Six hundred ninery-five (695) currently married nonsmoking women,
ages 50-79, with no previous hi'story of heart disease or stroke were followe&
based on their husband's self-reported smoking status in 1972=1974.
The results, after adjusting for age, systolic blood pressure, total plasma
cholesterol; obesity index and years of'~ marriage gave a relative risk of 14.9'
of deaths from ischemic heart disease for women married', to current or for-
mer smokers at entry compared with1 women married to never smokers. The
p value was not significant, p<.10!
Important methodological problems exi'st, with the Garland study. The
first is that Garland later reported a corrected relative risk of 2.7 (not 14.9
as reported in the 1985 publication). The p value is still < .10 and not
significant.
The second problem i's that after ten years of follow-up, only 19 deaths
from ischemic heart disease occurred. This small sample size is compounded
by the fact that 15 of the 19 deaths occurred in nonsmoking women married
to husbands who had'stopped smoking at entry. Without more detailed char-
acterization of these women's exposure to ETS, it is difficult to show an as-
sociation between ETS and ischemic heart disease. As the study di& not as-
certain number of cigarettes smoked per day in former smokers, it is not
pos,
grol
gro
exa
hor
hea:
suc
lacl
ma
3.
of
anc
(~1`
res
scr
tio
an,
ba
pu
1.
2.
3.
4.

ETS and Cardiovascular Disease 145
possible to measure any sustained' effects of' ETS in this former smoking
group.
Another methodological problem is that wives of former smokers were
grouped with wives of current smokers, and it is difficult to determine the
exact effect of ETS for this former smoking group.
Although the Garlan&study does make an attempt in a prospective co-
hort study to measure the effects of possible exposure to ETS on ischemic
heart disease, and does control for important cardiovascular confounders,
such as obesity, blood pressure and cholesterol,,the small sample size and the
lack of adequate measurement of' ETS in a former cigarette smoking group
make the results only suggestive and' certainly not definitive.
14.9
not
kiths
Jde&
ed
as-
as-
not
3. Gillis. The Gillis study (1989):consists of a prospective cohort comprise&
of men and women aged 45-641 years who resided in two towns, Renfrew
an& Paisley; in the west of' Scotland, between 1972 and 1976. Residents
(15;399):of these two towns who met the age and resid'encgcriteria (an 80%
response) agreed to participate; 7,997 were subjected to a cardiorespiratory
screening examination, a self-administered questionnaire that included ques-
tions on smoking behavior. The eventual sample was comprised of 3,960!men
an& 4,037 women where it was possible to study varying exposures to to-
bacco smoke by cohabitees. Four groups were established for analysiss
purposes:
1. Control-neither the case nor anyone living at the same address ha&ever
smoked.
2. Presumed ETS exposure in the home-the case had' never smoked but
lived at the same address as a subjea who had smoked.
3. Single smoking-the case was a smoker or an ex-smoker and lived at the
same address as a person who had never smoked.
4. Double smoking: the case was a smoker or an: ex-smoker who lived at
the same address as a subject who was also a smoker or ex-smoker.
Mortality was used as an endpoint and was obtained'from the National
Healthl Service. Cardiovascular signs and' symptoms were also noted. Data
presented were complete through December 1985, for an average follow-up
of1 LS years.
The authors present relative risks and 95% confidence intervals adjusted
for age, sex, social' class, diastolic blood pressure, serum cholesterol concen-
tration an& body mass index. Total mortality for ischemic heart disease was
higher among those reportedly exposed to ETS in the home than controls.
Women with ETS exposure in the home were broken into two dose re-
sponse categories for further analyses. These included: (I) the high exposure

146 Environmental Tobacco Smoke
group, where the woman's cohabitee smoked 15 or more cigarettes daily, and
(2) the low exposure group where the women's cohabitee smoked! less than
15 cigarettes daily. Age-adjusted mortality from ischemic heart disease was
higher for those in the high exposure category than in the low exposure
group.
Relative risk was adjusted for age, sex, social class and cardiovascular
variables including diastolic blood pressure, serum cholesterol concentrations
and body mass index. Compared with controls, the relative risk was 2.01 for
ischemic heart disease and was not significant.
The Gillis paper has several methodological problems. The first is that it
does not have sufficient power to demonstrate an association~ between~ ETS
and ischemic heart disease. The sample size is too small.
A second'problem is that the relative risk of 2.01 for ischemic heart dis-
ease for non-smokers compared with controls is too similar to the relative
risk of 2.27 for active smokers compared with controls to make sense. An
explanation for this is not clear, but may be due to small sample size as well.
Potential biases also exist in the Gillis study. One potential bias is that
those exposed to ETS within the home may have had higher exposures to
ETS outside of the home compared with controls. A second potential bias is
misdassification of women as non-smokers when they may be former smok-
ers or current smokers.
Although the Gallis study suggests an ~ association between ETS and' car-
diovascular mortality in non-smokers, the data lacks any statistical signifi-
cance. Also, the study reports some confusing and similar relative risks for
active and passive smokers, and' is confounded by several' important meth-
odological biases. This study shoul& be replicated in a much: larger study
population, with adequate statistical power.
4. Svcndsen. Svendsen (1987)!reports the results of the Multiple Risk Factor
Intervention Trial (MRFIT), conducted from 1973-1982. The trial consisted
of inen, aged 35-57, recruited from 18 cities in the United States. Males who
felliwithin the upper: 110-15% risk score distribution ~ for heart disease, based
on an index eomprised~of serum cholesterol concentration, cigarette smoking
and diastolic blood pressure, and free of overt coronary heart disease were
randomized to one of'two groups:, (1) special intervention or (2) usual care.
Participants in both groups were seen annually over six to eight years for risk
factor measurement and a medical' examination. A detailed smoking history
was obtained at baseline and at all subsequent annual visits. Cause of death
was evaluated by a committee of three cardiologists after examination of
death certificates and other medical records.
Fourteen hundred of 12,866 men reported that they had never smoked
at entry into the study. Of these 1400, 1,245 were married. Of the later
group, 286 were married to: women who smoked and 959 were marrie& to
women who did'not smoke.
